SOCIETY of Hospital Pharmacists of Australia ceo Kristin Michaels has been appointed to the Australian steering committee of All.Can, a global initiative which aims to identify improvements to the care pathway for cancer patients through the health system.
All.Can Australia plans to develop a research report this year giving a system-wide evaluation of Australian cancer care, and will also participate in a global patient survey, with the group currently active in Germany, Poland, Sweden and the UK as well as Australia.
Bristol-Myers Squibb is the foundation partner supporting All.Can in Australia, with other committee members including Raymond Chan, Professor of Nursing at Qld University of Technology; Ovarian Cancer Australia ceo Jane Hill; Sharon Millman from Lymphoma Australia and Alison Verhoeven, ceo of the Australian Healthcare and Hospitals Association.
More at www.all-can.org.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Feb 18
